These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 10070941

  • 1. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
    Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA.
    J Natl Cancer Inst; 1999 Mar 03; 91(5):429-33. PubMed ID: 10070941
    [Abstract] [Full Text] [Related]

  • 2. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M.
    Int J Cancer; 2002 Feb 20; 97(6):751-60. PubMed ID: 11857350
    [Abstract] [Full Text] [Related]

  • 3. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH, Li G, Yu J, Xu MS, Liu ZX.
    Zhonghua Zhong Liu Za Zhi; 2011 Sep 20; 33(9):654-60. PubMed ID: 22340044
    [Abstract] [Full Text] [Related]

  • 4. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
    Ma MT, He M, Wang Y, Jiao XY, Zhao L, Bai XF, Yu ZJ, Wu HZ, Sun ML, Song ZG, Wei MJ.
    Cancer Lett; 2013 Oct 01; 339(1):107-15. PubMed ID: 23879965
    [Abstract] [Full Text] [Related]

  • 5. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M.
    Breast Cancer Res Treat; 2013 Jun 01; 139(3):717-30. PubMed ID: 23780685
    [Abstract] [Full Text] [Related]

  • 6. Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.
    Liu F, Fan D, Qi J, Zhu H, Zhou Y, Yang C, Zhu Z, Xiong D.
    Life Sci; 2008 Sep 26; 83(13-14):496-501. PubMed ID: 18725232
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y, Wang H, Wei L, Li G, Yu J, Gao Y, Gao P, Zhang X, Wei F, Yin D, Zhou G.
    Breast Cancer Res Treat; 2010 Oct 26; 123(3):679-89. PubMed ID: 19967559
    [Abstract] [Full Text] [Related]

  • 8. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).
    Litman T, Brangi M, Hudson E, Fetsch P, Abati A, Ross DD, Miyake K, Resau JH, Bates SE.
    J Cell Sci; 2000 Jun 26; 113 ( Pt 11)():2011-21. PubMed ID: 10806112
    [Abstract] [Full Text] [Related]

  • 9. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.
    Wang Y, Zhao L, Xiao Q, Jiang L, He M, Bai X, Ma M, Jiao X, Wei M.
    Gynecol Oncol; 2016 Jun 26; 141(3):592-601. PubMed ID: 26644266
    [Abstract] [Full Text] [Related]

  • 10. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L, Ross DD.
    Oncogene; 2003 Oct 20; 22(47):7340-58. PubMed ID: 14576842
    [Abstract] [Full Text] [Related]

  • 11. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
    Ji N, Yuan J, Liu J, Tian S.
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec 20; 42(12):854-62. PubMed ID: 21106767
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE.
    Clin Cancer Res; 2001 Jan 20; 7(1):145-52. PubMed ID: 11205902
    [Abstract] [Full Text] [Related]

  • 13. Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/MXR/ABCG2.
    Kowalski P, Wichert A, Holm PS, Dietel M, Lage H.
    Cancer Gene Ther; 2001 Mar 20; 8(3):185-92. PubMed ID: 11332989
    [Abstract] [Full Text] [Related]

  • 14. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
    Nakamura Y, Oka M, Soda H, Shiozawa K, Yoshikawa M, Itoh A, Ikegami Y, Tsurutani J, Nakatomi K, Kitazaki T, Doi S, Yoshida H, Kohno S.
    Cancer Res; 2005 Feb 15; 65(4):1541-6. PubMed ID: 15735043
    [Abstract] [Full Text] [Related]

  • 15. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.
    Knutsen T, Rao VK, Ried T, Mickley L, Schneider E, Miyake K, Ghadimi BM, Padilla-Nash H, Pack S, Greenberger L, Cowan K, Dean M, Fojo T, Bates S.
    Genes Chromosomes Cancer; 2000 Jan 15; 27(1):110-6. PubMed ID: 10564593
    [Abstract] [Full Text] [Related]

  • 16. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
    Kowalski P, Stein U, Scheffer GL, Lage H.
    Cancer Gene Ther; 2002 Jul 15; 9(7):579-86. PubMed ID: 12082458
    [Abstract] [Full Text] [Related]

  • 17. Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference.
    Li WT, Zhou GY, Song XR, Chi WL, Ren RM, Wang XW.
    Neoplasma; 2005 Jul 15; 52(3):219-24. PubMed ID: 15875083
    [Abstract] [Full Text] [Related]

  • 18. Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins.
    Diah SK, Smitherman PK, Aldridge J, Volk EL, Schneider E, Townsend AJ, Morrow CS.
    Cancer Res; 2001 Jul 15; 61(14):5461-7. PubMed ID: 11454692
    [Abstract] [Full Text] [Related]

  • 19. Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells.
    Valinezhad Sani F, Palizban A, Mosaffa F, Jamialahmadi K.
    J Pharm Pharmacol; 2021 Jun 08; 73(7):922-927. PubMed ID: 33885909
    [Abstract] [Full Text] [Related]

  • 20. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
    Imai Y, Ishikawa E, Asada S, Sugimoto Y.
    Cancer Res; 2005 Jan 15; 65(2):596-604. PubMed ID: 15695404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.